i agree management should never set expectations that they can’t meet, but maybe things changed  that they did not expect during the trial that indicated those FA SSRA, was not needed and would be penalized at the end of the trial in terms of RRR % . It is also possible that management realizes that helping your largest shareholders accumulate more shares and % of the co  makes it easier not to look for investors when you can always go back to the trough for money from Hepalink. By promoting the company and artificially raising the Sp to say $5 to $7 or more short term does help to get more financing if you piss of Hepalink at higher finance price when all insiders know the true market value with a positive betonmace trial ,Just my conspiracy theory that is probably wrong, but you never know